13F filer · CIK 1579853
SENZAR ASSET MANAGEMENT, LLC
New York, NY · filing since Q4 2013 · last filing Oct 31, 2018
Reported value
$459.0M
$-44.7M vs prior
Positions
41
New / sold out
15 / 11
Added / reduced
5 / 21
Turnover
48.5%
buys $233.6M · sells $287.0M
Top-10 weight
60.5%
Biggest buys vs Q1 2016
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | LLYLILLY ELI & CO | +601,800 | – | +$47.4M |
| New | SANOFI | +1,103,300 | – | +$46.2M |
| New | ABBOTT LABS | +778,900 | – | +$30.6M |
| New | BIOGEN INC | +101,600 | – | +$24.6M |
| New | CENTENE CORP DEL | +172,800 | – | +$12.3M |
| New | ENDOLOGIX INC | +809,800 | – | +$10.1M |
| New | TESARO INC | +94,300 | – | +$7.9M |
| Added | SHIRE PLC | +42,500 | +35.2% | +$7.8M |
| New | MOLINA HEALTHCARE INC | +150,700 | – | +$7.5M |
| New | HALOZYME THERAPEUTICS INC | +785,744 | – | +$6.8M |
10 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2016
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | NEVRO CORP | -1,483,730 | -100.0% | $-83.5M |
| Sold out | ALLERGAN PLC | -143,748 | -100.0% | $-38.5M |
| Sold out | TEVA PHARMACEUTICAL INDS LTD | -558,889 | -100.0% | $-29.9M |
| Reduced | AMGEN INC | -113,368 | -42.1% | $-17.2M |
| Reduced | RETROPHIN INC | -785,103 | -70.4% | $-14.0M |
| Reduced | INTRA CELLULAR THERAPIES INC | -238,300 | -62.2% | $-9.3M |
| Reduced | ANTHEM INC | -60,900 | -29.8% | $-8.0M |
| Sold out | SELECT MED HLDGS CORP | -646,624 | -100.0% | $-7.6M |
| Sold out | ANI PHARMACEUTICALS INC | -223,871 | -100.0% | $-7.5M |
| Reduced | CONCERT PHARMACEUTICALS INC | -670,905 | -45.6% | $-7.5M |
22 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2016
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | LLYLILLY ELI & CO | 601,800 | $47.4M | 10.33% |
| 2 | SANOFISPONSORED ADR | 1,103,300 | $46.2M | 10.06% |
| 3 | ABBOTT LABSCOM | 778,900 | $30.6M | 6.67% |
| 4 | SHIRE PLCSPONSORED ADR | 163,200 | $30.0M | 6.55% |
| 5 | BIOGEN INCCOM | 101,600 | $24.6M | 5.35% |
| 6 | AMGEN INCCOM | 155,932 | $23.7M | 5.17% |
| 7 | HEALTHWAYS INCCOM | 1,827,829 | $21.1M | 4.60% |
| 8 | AETNA INC NEWCOM | 162,700 | $19.9M | 4.33% |
| 9 | ANTHEM INCCOM | 143,800 | $18.9M | 4.12% |
| 10 | UNIVERSAL HLTH SVCS INCCL B | 114,700 | $15.4M | 3.35% |
31 more rows. Subscribe for $29/month to see every row, download the data and use the API.